Avita Medical hires Erin Liberto as CCO
Medical device company Avita Medical has named Erin Liberto as the company’s chief commercial officer.
Liberto will have responsibility for successful execution of the company’s comprehensive commercial strategy including the further development of the company’s sales, reimbursement and marketing efforts, and will report directly to CEO Dr Michael Perry.
“Erin’s extensive experience in the global dermatology markets, including a proven track record of successful US product launches, will be instrumental as we position ReCell in the US burns market following our anticipated PMA approval next year,” said Dr Perry.
“We are laying the foundation for our future growth across multiple indications, and I’m energised to be working with Erin as we continue to leverage our clinical progress across a broad range of indications.”
Liberto was most recently VP of marketing, Topical Dermatology at Allergan where she led the commercial operations of marketing and strategic communication for two dermatology franchises: SkinMedica, a cash-pay, physician-dispensed topical aesthetics business unit and the Medical Dermatology division, which included reimbursed topical pharmaceutical products for skin conditions and where she oversaw more than US$650 m of business revenue.
Breast augmentation procedure uses 3D-printed scaffolds
3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
